Saturday (26.10.2024)

08:30 – 11:00

Room: Marsilius Saal

Separate registration required Workshop Working towards harmonization of clinical trial reporting in Hodgkin Lymphoma

  • Sally Barrington
  • Sven Borchmann
  • Carsten Kobe
  • Wouter Plattel
  • Davide Rossi

08:30 – 11:00

Room: Großer Saal

Educational EHA-LYG / GHSG Joint Educational “Emerging Therapeutic Concepts in B-Cell Lymphomas”

  • Igor Aurer
  • Bastian von Tresckow
  • 08:30–08:33

    Introduction

  • 08:33–08:55

    Molecular and microenvironmental vulnerabilities of B-cell lymphomas

    • Sirpa Leppä
  • 08:55–09:17

    Is there a role for CAR T-cell therapy in first-line Tx of indolent lymphoma?

    • Marie Jose Kersten
  • 09:17–09:39

    Who needs bispecific antibodies as first-line treatment in aggressive lymphoma?

    • Catherine Thieblemont
  • 09:39–10:01

    How to implement novel ADCs in the first-line treatment of lymphoma

    • Pier Luigi Zinzani
  • 10:01–10:23

    Perspectives of small molecule based first-line therapy of LBCL

    • Theodoros Vasilakopoulos
  • 10:23–10:45

    Treatment and Trial Landscape for Malignant Lymphoma in China

    • Yuqin Song

11:30 – 13:00

Room: Großer Saal

Scientific Session Limited Stages

  • Marc André
  • Lena Specht
  • 11:30–11:50

    IIntro: Treatment concepts in early-stage HL

    • Marc André
  • 11:50–12:10

    Viewpoint: Systemic Therapy only in the future?

    • Ranjana Advani
  • 12:10–12:30

    Viewpoint: CMT (is it there to stay?)

    • Joachim Yahalom
  • Abstract Talk

    Factors driving treatment intensity in the whole cohort of patients with early-stage favorable (I-IIA), nonbulky Hodgkin Lymphoma enrolled in the RAFTING trial (NCT 04866654).

      Andrea Gallamini
  • Abstract Talk

    Nodular lymphocyte predominant Hodgkin lymphoma in the Nordic countries – characteristics, treatment and survival

      Ilja Kalashnikov
  • Abstract Talk

    SERUM TARC COMBINED WITH FDG-PET IMAGING IMPROVES INTERIM RESPONSE EVALUATION IN CLASSIC HODGKIN LYMPHOMA: A RETROSPECTIVE ANALYSIS OF GERMAN HODGKIN STUDY GROUP HD16 AND HD18 TRIALS

      Wouter Plattel

13:15 – 14:45

Room: Großer Saal

Satellite Symposium (by BeiGene Switzerland GmbH) The evolving role of BTKis in the treatment of B-cell lymphomas

  • Christian Buske
  • 13:15–13:20

    Welcome and Introduction

    • Christian Buske
  • 13:20–13:40

    BTKis in indolent lymphomas (FL, MZL)

    • Catherine Thieblemont
  • 13:40–13:58

    BTKis in WM

    • Christian Buske
  • 13:58–14:14

    BTKis in MCL

    • David Lewis
  • 14:14–14:29

    Future developments (CDAC, BCL2, anti PD1/PDL1)

    • Anna Maria Frustaci
  • 14:29–14:44

    Panel discussion, audience Q&A

  • 14:44–14:45

    Closure and farewell

    • Christian Buske

15:15 – 17:00

Room: Großer Saal

Main Program Opening and Award Ceremony

  • 15:15–15:30

    Welcome Address

    • Peter Borchmann
    • Volker Diehl
  • 15:30–16:00

    Award Ceremony

    • Peter Borchmann
    • Sven Borchmann
    • Paul J. Bröckelmann
    • Dennis Eichenauer
  • 16:00–17:00

    Keynote Lecture

    • Linda Partridge

17:15 – 20:00

Room: Foyer (First Floor)

Main Program Poster Session & Welcome Reception

  • All poster presenters are required to be present at their poster boards from 17:15 to 19:00

ISHL13 Program at a Glance (PDF)

ISHL13 Program at a Glance (PDF)

Save the date

Save the event to your calendar

Archive

You can explore the ISHL12 program to get an impression of the broad spectrum and diversity of the congress.